Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TDX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,461
Award facts
- Contract value 100% obligated
- $10,460.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,460.57 to AmerSourceBergen Drug Corp on January 8, 2026, for the supply of TRELEGY ELLIPTA 200-62.5-25 (a combination inhalation medication for respiratory conditions) in a 60-dose configuration. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating open and competitive procurement. This delivery order is a child contract under AmerSourceBergen's parent company Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, serving as the primary vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally.
AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's performance location is based in Conshohocken, with an ultimate completion date of January 9, 2026. This award reflects the contractor's ongoing role in fulfilling the DLA's extensive pharmaceutical supply requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities that support military treatment facilities and federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F3TDX?
SPE2DR26F3TDX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F3TDX worth?
The government has obligated $10,461 on SPE2DR26F3TDX.
Is contract SPE2DR26F3TDX an order under another contract?
Yes. SPE2DR26F3TDX is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TDX competed?
The extent of competition for SPE2DR26F3TDX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award